Banque Cantonale Vaudoise Sarepta Therapeutics, Inc. Transaction History

Banque Cantonale Vaudoise

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$62.69 - $88.44 $2,444 - $3,449	39 Added 9.11%	467 $35,000
Q1 2022 May 09, 2022	SELL	$63.15 - $90.42 $53,361 - $76,404	-845 Reduced 66.38%	428 $33,000
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $22,874 - $29,428	-296 Reduced 18.87%	1,273 $115,000
Q3 2021 Oct 29, 2021	SELL	$65.97 - $92.48 $149,224 - $209,189	-2,262 Reduced 59.04%	1,569 $145,000
Q2 2021 Aug 11, 2021	SELL	$69.38 - $86.75 $95,813 - $119,801	-1,381 Reduced 26.5%	3,831 $298,000
Q1 2021 May 11, 2021	BUY	$72.25 - $168.95 $15,028 - $35,141	208 Added 4.16%	5,212 $389,000
Q4 2020 Feb 05, 2021	SELL	$125.56 - $178.74 $258,402 - $367,846	-2,058 Reduced 29.14%	5,004 $852,000
Q3 2020 Oct 30, 2020	BUY	$127.12 - $172.34 $194,874 - $264,197	1,533 Added 27.73%	7,062 $991,000
Q2 2020 Jul 22, 2020	BUY	$93.0 - $171.7 $242,265 - $447,278	2,605 Added 89.09%	5,529 $887,000
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $18,535 - $29,618	-225 Reduced 7.15%	2,924 $286,000
Q4 2019 Feb 10, 2020	BUY	$76.53 - $135.58 $240,992 - $426,941	3,149 New	3,149 $406,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.